PROTAGENIC THERAPEUTICS (PTIX) is a publicly traded Healthcare sector company. As of August 4, 2026, PTIX trades at $0.74 with a market cap of $0 and a P/E ratio of -0.66. PTIX moved -41.27% today. Year to date, PTIX is -71.74%; over the trailing twelve months it is -90.99%. Its 52-week range spans $0.25 to $15.54. Rallies surfaces PTIX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for PTIX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $0.74 |
| Market Cap | $0 |
| P/E Ratio | -0.66 |
| EPS | $-1.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.54 |
| 52-Week Low | $0.25 |
| Volume | 1.92M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-5.53M |
| Gross Margin | 0.00% |
PTIX analyst coverage data. Average price target: $0.00.